Trial Profile
A Study of the Safety of Ramelteon [ROZEREM; Takeda] in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jun 2013
Price :
$35
*
At a glance
- Drugs Ramelteon (Primary)
- Indications Insomnia
- Focus Adverse reactions
- Sponsors Takeda Global Research and Development Center
- 06 Dec 2007 New trial record.